Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.570
-0.270 (-14.67%)
At close: Apr 4, 2025, 4:00 PM
1.560
-0.010 (-0.64%)
After-hours: Apr 4, 2025, 7:58 PM EDT

Sunshine Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-5.13-4.51-26.74-12.44-2.78
Upgrade
Depreciation & Amortization
0.220.150.030.010.01
Upgrade
Asset Writedown & Restructuring Costs
--18.33--
Upgrade
Stock-Based Compensation
0.01--0.920.05
Upgrade
Other Operating Activities
---0.019.792.11
Upgrade
Change in Accounts Receivable
-2.34-0.59-0.52-0.01-0
Upgrade
Change in Inventory
-6.01-2.370.04-0.08-0.01
Upgrade
Change in Accounts Payable
3.98-1.363.36-0.02-0.04
Upgrade
Change in Income Taxes
-0.81-0.070.24--
Upgrade
Change in Other Net Operating Assets
-2.46-0.020.03-00
Upgrade
Operating Cash Flow
-12.53-8.78-5.25-1.83-0.66
Upgrade
Capital Expenditures
-1.66-0.08-0.19--0
Upgrade
Cash Acquisitions
---14.35--
Upgrade
Sale (Purchase) of Intangibles
-0.32-0.71-0.11--
Upgrade
Other Investing Activities
-0.340.130.03--
Upgrade
Investing Cash Flow
-2.32-0.66-14.62--0
Upgrade
Long-Term Debt Issued
0.35--3.321.67
Upgrade
Total Debt Issued
0.35--3.321.67
Upgrade
Long-Term Debt Repaid
--0.13-1.93-0.48-0.11
Upgrade
Total Debt Repaid
--0.13-1.93-0.48-0.11
Upgrade
Net Debt Issued (Repaid)
0.35-0.13-1.932.841.57
Upgrade
Issuance of Common Stock
12.084.0943.56--
Upgrade
Repurchase of Common Stock
-3.14-0.54-0.1--
Upgrade
Other Financing Activities
---2.060.060.04
Upgrade
Financing Cash Flow
9.293.4339.472.91.61
Upgrade
Foreign Exchange Rate Adjustments
-1.040.470.18-0.02-0
Upgrade
Net Cash Flow
-6.61-5.5319.781.060.95
Upgrade
Free Cash Flow
-14.19-8.86-5.44-1.83-0.66
Upgrade
Free Cash Flow Margin
-40.68%-36.76%-125.24%-800.75%-922.13%
Upgrade
Free Cash Flow Per Share
-20.22-728.04---
Upgrade
Cash Interest Paid
--0.050.040.02
Upgrade
Levered Free Cash Flow
-12.4-8.2-4.35-0.91-0.44
Upgrade
Unlevered Free Cash Flow
-12.4-8.12-4.33-0.7-0.34
Upgrade
Change in Net Working Capital
7.014.49-1.370.110.04
Upgrade
Updated Nov 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q